The forecast for liver malignant neoplasms mortality among men in Brazil indicates a gradual upward trend from 2024 to 2028. The mortality rate starts at 11.9 per hundred thousand in 2024 and is expected to increase incrementally to 12.6 by 2028. This represents a year-on-year growth rate of approximately 1.4% from 2024 to 2025, and a compound annual growth rate of about 1.3% from 2024 to 2028. These increases suggest a persistent challenge in controlling liver cancer mortality in Brazil over the forecast period.
Future trends to watch for include emerging treatment options, advancements in early detection, and public health initiatives aimed at risk factor reduction, such as hepatitis B and C prevention and control, as these could significantly impact mortality rates moving forward.
